Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/2162402X.2015.1078061 http://scihub22266oqcxt.onion/10.1080/2162402X.2015.1078061 C4801443!4801443!27057456     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncoimmunology 2016 ; 5 (2): ä Nephropedia Template TP {{tp|p=27057456|t=2016. Improvement of immunogenic chemotherapy by STAT3 inhibition |pdf=|usr=}}{{27057456}} gab.com Text Improvement of immunogenic chemotherapy by STAT3 inhibition JO: Oncoimmunology http://www.kidney.de/pget.php?&tw=1&pmid=27057456 #FOAvip The inhibition of STAT3 may exert cell-autonomous cytotoxic and cytostatic effects, yet may also stimulate anticancer immunosurveillance through the neutralization of immunosuppressive circuitries. In addition, STAT3 inhibition in cancer cells may stimulate the type 1 interferon response elicited by anthracyclines. This pathway results in an enhanced chemotherapy-associated anticancer immune response with improved therapeutic efficacy. Hence, combination therapies that include immunogenic cell death (ICD) inducers and STAT3 inhibitors can be envisaged. Twit Text FOAVip Improvement of immunogenic chemotherapy by STAT3 inhibition ????Oncoimmunology http://www.kidney.de/pget.php?&tw=1&pmid=27057456 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27057456 #FOAvip English Wikipedia <ref>{{Cite pmid|27057456}}</ref> Improvement of immunogenic chemotherapy by STAT3 inhibition #MMPMID27057456 Yang H; Yamazaki T; Pietrocola F; Zhou H; Zitvogel L; Ma Y; Kroemer G Oncoimmunology 2016[Feb]; 5 (2): ä PMID27057456show ga The inhibition of STAT3 may exert cell-autonomous cytotoxic and cytostatic effects, yet may also stimulate anticancer immunosurveillance through the neutralization of immunosuppressive circuitries. In addition, STAT3 inhibition in cancer cells may stimulate the type 1 interferon response elicited by anthracyclines. This pathway results in an enhanced chemotherapy-associated anticancer immune response with improved therapeutic efficacy. Hence, combination therapies that include immunogenic cell death (ICD) inducers and STAT3 inhibitors can be envisaged. äImprovement of immunogenic chemotherapy by STAT3 inhibition (epmc).pdf DeepDyve Pubget Overpricing